MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

Search

10X Genomics Inc (Class A)

Closed

SectorHealthcare

8.46 2.3

Overview

Share price change

24h

Current

Min

8.27

Max

8.66

Key metrics

By Trading Economics

Income

-13M

-49M

Sales

13M

165M

EPS

-0.136

Profit margin

-29.71

Employees

1,306

EBITDA

-14M

-38M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+89.52% upside

Dividends

By Dow Jones

Next Earnings

8 May 2025

Market Stats

By TradingEconomics

Market Cap

925M

Previous open

6.16

Previous close

8.46

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

10X Genomics Inc (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

28 Apr 2025, 23:27 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28 Apr 2025, 23:07 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28 Apr 2025, 23:03 UTC

Earnings

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28 Apr 2025, 23:47 UTC

Market Talk

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28 Apr 2025, 23:17 UTC

Earnings

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28 Apr 2025, 23:17 UTC

Earnings

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28 Apr 2025, 23:13 UTC

Earnings

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28 Apr 2025, 23:13 UTC

Earnings

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28 Apr 2025, 23:13 UTC

Earnings

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28 Apr 2025, 23:13 UTC

Earnings

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28 Apr 2025, 23:08 UTC

Earnings

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28 Apr 2025, 23:08 UTC

Earnings

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28 Apr 2025, 23:08 UTC

Earnings

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28 Apr 2025, 23:04 UTC

Earnings

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28 Apr 2025, 23:04 UTC

Earnings

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28 Apr 2025, 23:04 UTC

Earnings

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28 Apr 2025, 23:04 UTC

Earnings

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28 Apr 2025, 23:00 UTC

Earnings

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28 Apr 2025, 23:00 UTC

Earnings

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28 Apr 2025, 23:00 UTC

Earnings

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28 Apr 2025, 23:00 UTC

Earnings

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28 Apr 2025, 22:57 UTC

Top News

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28 Apr 2025, 22:55 UTC

Earnings

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28 Apr 2025, 22:55 UTC

Earnings

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28 Apr 2025, 22:55 UTC

Earnings

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28 Apr 2025, 22:52 UTC

Earnings

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28 Apr 2025, 22:52 UTC

Earnings

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28 Apr 2025, 22:52 UTC

Earnings

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28 Apr 2025, 22:52 UTC

Earnings

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28 Apr 2025, 22:46 UTC

Earnings

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Peer Comparison

Price change

10X Genomics Inc (Class A) Forecast

Price Target

By TipRanks

89.52% upside

12 Months Forecast

Average 15.73 USD  89.52%

High 26 USD

Low 12 USD

Based on 12 Wall Street analysts offering 12 month price targets for10X Genomics Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

6

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

8.03 / 8.31Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.